Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

423
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
423
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

310
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
310
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.4K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.4K
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

325
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
325
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

470
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
470

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Singapore.

Expert review of pharmacoeconomics & outcomes research·2024
Same author

Establishing priorities on the range of conditions managed by UK community practitioner nurse prescribers: A modified Delphi consensus study.

Journal of advanced nursing·2018
Same author

Should patients complete the course?

Nursing standard (Royal College of Nursing (Great Britain) : 1987)·2017
Same author

How can we reduce excessive prescribing?

Nursing standard (Royal College of Nursing (Great Britain) : 1987)·2017
Same author

Standards help to keep nurses and patients safe.

Nursing standard (Royal College of Nursing (Great Britain) : 1987)·2017
Same author

Fair blame, not no blame.

Nursing standard (Royal College of Nursing (Great Britain) : 1987)·2017
Same journal

Effect of artificial intelligence on nursing documentation and patient safety.

Nursing standard (Royal College of Nursing (Great Britain) : 1987)·2026
Same journal

Strategies for responding to anger from patients, relatives and carers.

Nursing standard (Royal College of Nursing (Great Britain) : 1987)·2026
Same journal

Nurses' role in detecting early and subtle signs of patient deterioration in acute hospitals.

Nursing standard (Royal College of Nursing (Great Britain) : 1987)·2026
Same journal

Pulse oximetry: exploring its role, limitations and challenges in clinical practice.

Nursing standard (Royal College of Nursing (Great Britain) : 1987)·2026
Same journal

Anorexia nervosa: identification and management by non-specialist nurses.

Nursing standard (Royal College of Nursing (Great Britain) : 1987)·2026
Same journal

Skin and soft tissue abscesses: assessment and management.

Nursing standard (Royal College of Nursing (Great Britain) : 1987)·2026
See all related articles

Related Experiment Video

Updated: Mar 19, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

31.5K

Medicine management.

Matt Griffiths1

  • 1Birmingham City University.

Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|June 9, 2016
PubMed
Summary
This summary is machine-generated.

Patients needing medicines not available through the National Health Service (NHS) have limited options. Explore alternative access routes and compassionate use programs for unlicensed medicines when NHS provision is not possible.

More Related Videos

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.4K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.5K

Related Experiment Videos

Last Updated: Mar 19, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

31.5K
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.4K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.5K

Area of Science:

  • Medicine Access
  • Pharmaceutical Policy
  • Healthcare Navigation

Background:

  • The National Health Service (NHS) provides a comprehensive healthcare system in the UK.
  • Access to certain medications may be restricted due to availability, cost, or regulatory status.
  • Physicians may encounter situations where patients require treatments not routinely commissioned by the NHS.

Purpose of the Study:

  • To outline potential strategies for accessing medications not available on the NHS.
  • To provide guidance for healthcare professionals facing such clinical scenarios.
  • To inform patients about alternative pathways for obtaining necessary treatments.

Main Methods:

  • Review of current UK pharmaceutical regulations and guidelines.
  • Examination of compassionate use and named patient program frameworks.
  • Analysis of international drug access schemes.
  • Consultation with patient advocacy groups and pharmaceutical manufacturers.

Main Results:

  • Several legal and ethical pathways exist for accessing unlicensed or unavailable medicines.
  • Compassionate use programs allow access to investigational drugs for patients with serious conditions.
  • Named patient programs facilitate the import of specific drugs for individual patients.
  • Off-label use requires careful consideration of evidence and risk-benefit.

Conclusions:

  • Healthcare professionals can explore compassionate use, named patient programs, or special access schemes.
  • Thorough documentation, informed consent, and adherence to regulatory requirements are crucial.
  • Patient advocacy and collaboration with pharmaceutical companies are key to successful access.